Clinical trial
Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in…
NCT00298350 · Gilead Sciences, Industry · Completed
Key facts
| NCT number | NCT00298350 |
|---|---|
| Title | Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART. |
| Official title | Phase 2 Study of the Treatment of Antiretroviral Treatment-Experienced Subjects Comparing Ritonavir-Boosted GS-9137 (GS-9137/r) vs. a Comparator Ritonavir-Boosted Protease Inhibitor (CPI/r) in Combination With Background ART. |
| Lead sponsor | Gilead Sciences, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV, HIV-1, Human Immunodeficiency Virus |
| Intervention type | Drug |
| Interventions | GS-9137 - A Novel HIV-1 Integrase Inhibitor |
| Enrollment | 278 |
| Start date | Feb 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Mar 2, 2006 |
| Last update posted | Jul 29, 2008 |
| Countries | Puerto Rico, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: